Community Health Systems, Inc. (FRA:CG5)
Germany flag Germany · Delayed Price · Currency is EUR
2.920
0.00 (0.00%)
At close: Nov 28, 2025

Community Health Systems Statistics

Total Valuation

FRA:CG5 has a market cap or net worth of EUR 412.76 million. The enterprise value is 10.45 billion.

Market Cap412.76M
Enterprise Value 10.45B

Important Dates

The next estimated earnings date is Thursday, February 19, 2026.

Earnings Date Feb 19, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 132.19M
Shares Outstanding n/a
Shares Change (YoY) +1.75%
Shares Change (QoQ) +0.23%
Owned by Insiders (%) 9.51%
Owned by Institutions (%) 60.21%
Float 87.23M

Valuation Ratios

The trailing PE ratio is 1.47.

PE Ratio 1.47
Forward PE n/a
PS Ratio 0.04
PB Ratio -0.51
P/TBV Ratio n/a
P/FCF Ratio 3.39
P/OCF Ratio 0.98
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.97, with an EV/FCF ratio of 85.75.

EV / Earnings 37.27
EV / Sales 0.96
EV / EBITDA 6.97
EV / EBIT 11.12
EV / FCF 85.75

Financial Position

The company has a current ratio of 1.47

Current Ratio 1.47
Quick Ratio 1.10
Debt / Equity n/a
Debt / EBITDA 6.49
Debt / FCF 78.62
Interest Coverage 1.24

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 4.98%
Return on Invested Capital (ROIC) 6.39%
Return on Capital Employed (ROCE) 9.77%
Revenue Per Employee 205,266
Profits Per Employee 5,341
Employee Count60,000
Asset Turnover 0.93
Inventory Turnover 23.10

Taxes

In the past 12 months, FRA:CG5 has paid 67.33 million in taxes.

Income Tax 67.33M
Effective Tax Rate 13.93%

Stock Price Statistics

The stock price has decreased by -13.61% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -13.61%
50-Day Moving Average 2.85
200-Day Moving Average 2.72
Relative Strength Index (RSI) 51.77
Average Volume (20 Days) 335

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.98

Income Statement

In the last 12 months, FRA:CG5 had revenue of EUR 10.78 billion and earned 280.41 million in profits. Earnings per share was 2.10.

Revenue10.78B
Gross Profit 4.52B
Operating Income 921.34M
Pretax Income 483.25M
Net Income 280.41M
EBITDA 1.23B
EBIT 921.34M
Earnings Per Share (EPS) 2.10
Full Income Statement

Balance Sheet

The company has 104.83 million in cash and 9.58 billion in debt, giving a net cash position of -9.48 billion.

Cash & Cash Equivalents 104.83M
Total Debt 9.58B
Net Cash -9.48B
Net Cash Per Share n/a
Equity (Book Value) -810.54M
Book Value Per Share -9.57
Working Capital 869.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 420.18 million and capital expenditures -298.31 million, giving a free cash flow of 121.88 million.

Operating Cash Flow 420.18M
Capital Expenditures -298.31M
Free Cash Flow 121.88M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 41.91%, with operating and profit margins of 8.55% and 2.60%.

Gross Margin 41.91%
Operating Margin 8.55%
Pretax Margin 4.48%
Profit Margin 2.60%
EBITDA Margin 11.44%
EBIT Margin 8.55%
FCF Margin 1.13%

Dividends & Yields

FRA:CG5 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.75%
Shareholder Yield -1.75%
Earnings Yield 67.93%
FCF Yield 29.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:CG5 has an Altman Z-Score of 0.95 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.95
Piotroski F-Score 8